NERV as of Oct 31 · 16:11 ET
NERVNasdaqPharmaceutical Preparations

Minerva Neurosciences, Inc. · Brief

Next report

6 days

Nov 6est.Q3 FY26

Expected move

No implied move.

Implied vs realized

1 reportHistory
—≥ implied
Q2 FY26±82.1%▼−3.83%×0.05
quarterimplied−85%0+85%realized×
Q2 FY26±82.1%▼−3.83%×0.05
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 6 report · est.

Bull2

7disclosed supplier and customer ties in SEC filingsSEC filings
+6.70%change in shares held by the ten largest reporting managers over the latest quarter13F · Jun 30 '26

Bear2

4 of 21of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
12managers whose positions together make up four fifths of the reported value13F · Jun 30 '26
AI captions · Sep 16 '26once per report · top 2 per case

Linked exposure

NERV report session

No linked exposure.

Latest changes

30 daysAll changes

No changes.

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.